Description: The panel at this session of the SOA 1997 Palm Desert Spring Meeting addresses possible strategies to identify and control factors causing medical inflation.

Description: Presented at October 2001 Annual Meeting. Panelists provide insight into the factors driving the cost increase of prescription drugs and how these factors are being addressed. Strategies include drug utilization review, manufacturer contracting, benefit design, formularies, pharmaceutical pricing, therapeutic substitution, physical education, and introduction of new pharmaceuticals. Also discussed are pharmacoeconomic benefit considerations when studying integrated medical and pharmacy expenses.

Description: Full version of Health Section News, December 2000, Issue No. 39.

Description: Current Status of managing costs & increasing costs, Future Direction of Consumerism, technology and defined contribution health plans. Issue No. 39.

Description: Panelists discuss the various types of risks in health insurance and health-care delivery, and various types of risk-absorption mechanisms for sharing these risks among providers, insurers, employers, and employees. In addition, they address the management of the risk from a corporate perspective, which will include bottom-line earnings and marketing goals and objectives. From the 1987 Record of Society of Actuaries, Vol. 13, No. 4B.

Description: This article details the plans of what the Entrepreneurial Section intends to do in 2008 including webcasts, meetings, vendor referral program, networking opportunities and improved communications.

Description: January 2008 The Independent Consultant – section newsletter of the Entrepreneurial Section

Description: The Health Section Council HSC of the Society of Actuaries approved and funded a project to study the cost impact on plan sponsor retiree pharmacy costs when Medicare Part D is implemented in 2006. Actuarial & Health Care Solutions, LLC AHCS was retained by HSC to perform the project. This report provides estimated savings for several of the options that will be available to plan sponsors after implementation of the Medicare prescription drug program.

Description: This report provides estimated savings for several of the options that are available to plan sponsors after implementation of the Medicare prescription drug program.

Description: These are the exhibits and appendices accompanying the paper Estimated Impact of Medicare Part D on Retiree Prescription Drug Costs.